Systematic Global Macro Investing with GMO’s Martin Emery

Episode Summary

Executive Summary: Martin Emery of GMO argues that the traditional 60/40 portfolio is entering a long period of near-zero expected return, while inflation, rising rates, and Fed balance-sheet contraction make beta riskier and diversification scarcer. GMO favors relative-value, cross-asset, and cross-country opportunities—especially long/short expressions in equities, bonds, currencies, and commodities—over passive core exposure.

Main Topics: The end of the reliable 60/40 portfolio: Emery says GMO’s models imply 60/40 offers essentially zero expected return, making the traditional 'core plus satellites' portfolio construction less effective and potentially dangerous. Inflation and the Fed’s policy dilemma: The discussion centers on persistent inflation, the difficulty of forecasting it, and the Fed’s struggle to tame it without causing a recession or asset-market disruption. Why GMO prefers relative value over outright beta: GMO sees little return in simply owning equities or bonds, but sees strong opportunity in long/short trades across countries and asset classes where valuation gaps are wide. Bond markets as poor diversifiers: With yields still low and inflation high, bonds are viewed as unattractive on return and less useful as portfolio insurance because they may no longer diversify equity risk. Equity opportunity through country dispersion: The team sees expensive markets like the U.S. as poor long-term bets and prefers being long cheaper regions such as parts of Europe and emerging markets. Systematic macro process at GMO: Emery explains GMO’s framework: long-term fair value, carry, purchasing power parity, and shorter-term sentiment indicators including price trends, news, and natural-language signals. Fed balance sheet, liquidity, and market distortions: They discuss research showing that QE supported asset prices and that balance-sheet contraction may pressure markets and unwind bubbles that liquidity helped sustain.

Key Arguments: The expected return of a 60/40 portfolio is essentially zero or cash-like for an extended period, not just for one or two years. Traditional portfolio construction that starts with 60/40 and adds small alternatives around the edges is no longer adequate; alternatives need to become part of the core. Inflation is hard to forecast, but current market pricing may be too optimistic about how quickly it will fade. The Fed is trying to fight inflation but faces a tradeoff: act aggressively and risk recession, or stay loose and risk persistent inflation. Bonds are unattractive because yields are low and their diversification benefit is weakening when bond risk also hurts equities. GMO sees more opportunity in relative-value equity trades across regions than in owning broad equity beta outright. Commodity and currency opportunities are more compelling when expressed tactically and relatively, not as permanent strategic long positions. Fed balance-sheet expansion likely boosted asset prices and allowed bubbles to persist longer; contraction could work in the opposite direction. The 'Fed put' still exists in a modified form, but market expectations of policy support have become circular and potentially unhealthy. Investors should not assume 'this time is completely different'; historical analogs remain useful for understanding current macro regimes.

Data Points: 60/40 expected return: Essentially zero or cash at best - Emery’s view of the long-term return outlook for a classic 60/40 portfolio Time period of weak 60/40 returns: Plenty of 10-year periods of zero return over 100 years - Used to argue the current regime could last a long time Inflation print mentioned: CPI ex Food ex Energy had a six in front of it - Used as evidence that underlying inflation remains elevated U.S. equity valuation: Shiller P/E getting towards the 30s; normal P/E in the low 20s - Example of expensive U.S. equity valuations relative to other regions Market rate-hike expectation: 75 basis point rise was off the table - Referenced as a factor that temporarily reassured markets Fed research window referenced: 2009 to about 2020 - Period in which balance-sheet expansion was said to have supported equities Investing horizon for currency fair value: 7 to 10 years - GMO’s long-term horizon for currency valuation and return modeling Portfolio holding period: Over a few months - Typical timeframe for GMO’s tactical positioning and sentiment adjustments

Pivotal Quotes: "the expected return for 60-40 is essentially zero or cash at best" — Martin Emery: Summarizing GMO’s long-term outlook for traditional balanced portfolios "you need to be thinking much more about things that are alternative to 60-40 portfolios" — Martin Emery: Advice on how portfolio construction should change in the current regime "the opportunity for macro alpha ... are the best we've seen in the 20-year history of running the SGM systematic global macro portfolio" — Transcript reading of GMO paper summary: Characterizing the scale of relative-value opportunity in current markets

Implications: Listeners should expect a tougher regime for passive balanced portfolios and a greater premium on flexibility, valuation discipline, and diversification beyond stocks and bonds. Macro, relative-value, and cross-asset strategies may be more valuable if inflation and policy volatility persist.